1. Stone N, Robinson J, Lichtenstein A, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2013. doi: 10.1161/1101.cir.0000437738.0000463853.0000437737a . This is the 2013 U.S cholesterol guideline as discussed in this paper.
2. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust:, 2011: Institute of Medicine;2011.
3. Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013. doi: 10.1161/1101.cir.0000437741.0000448606.0000437798 . This is the 2013 U.S risk assessment guideline discussed in this paper.
4. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013.
5. Lloyd-Jones D, Goff D, Stone N. Letter to the editor: Statins, risk assessment, and the new American prevention guidelines. Lancet. 2014;383:600–2. The letter addresses criticisms of the Pooled Cohort Equations for ASCVD risk prediction.